SPR Therapeutics’ SPRINT extensa™ Peripheral Nerve Stimulation (PNS) System is the only FDA-cleared percutaneous PNS System. SPRINT PNS is indicated for both chronic and acute pain and is the industry’s only dual lead capable PNS platform. SPRINT, a minimally invasive and non-opioid 60-day therapy, has demonstrated significant and sustained pain relief across multiple studies. For additional information regarding safety and efficacy visit www.sprtherapeutics.com.
SPR Therapeutics’ SPRINT extensa™ Peripheral Nerve Stimulation (PNS) System is the only FDA-cleared percutaneous PNS System. SPRINT PNS is indicated for both chronic and acute pain and is the industry’s only dual lead capable PNS platform. SPRINT, a minimally invasive and non-opioid 60-day therapy, has demonstrated significant and sustained pain relief across multiple studies. For additional information regarding safety and efficacy visit www.sprtherapeutics.com.